CBLL

CeriBell, Inc.

28.84

Top Statistics
Market Cap 1 B Forward PE -24.52 Revenue Growth 48.10 %
Current Ratio 2.67 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -60.21 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -34.76 Enterprise / Revenue 19.80 Price To Sales Trailing12 Months 17.21
Profitability
Profit Margins -60.21 % Operating Margins -57.79 %
Balance Sheet
Total Cash 14 M Total Cash Per Share 0.3940 Total Debt 22 M
Total Debt To Equity 193.57 Current Ratio 2.67 Book Value Per Share -23.53
All Measures
Short Ratio 162.00 % Message Board Id finmb_531649318 Shares Short Prior Month 178466
City Sunnyvale Uuid 4108d685-a975-3c79-bbba-4795c704a81e Previous Close 27.68
First Trade Date Epoch Utc 1 B Book Value -23.53 Total Debt 22 M
Volume 73743 Fifty Two Week Low 23.00 Total Cash Per Share 0.3940
Total Revenue 60 M Shares Short Previous Month Date 1 B Target Median Price 31.50
Max Age 86400 Recommendation Mean 1.20 Sand P52 Week Change 0.3133
Operating Margins -57.79 % Target Mean Price 31.50 Net Income To Common -36153000
Ask 29.06 Implied Shares Outstanding 35 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 150830 Average Volume10days 150830
Total Cash 14 M Next Fiscal Year End 1 B Revenue Per Share 10.90
Held Percent Insiders 0.2696 Ebitda Margins -56.95 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 27.68
Target Low Price 31.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 26.75
Open 27.69 Dividend Yield 0.00 % State CA
Time Zone Short Name EST Trailing Eps -1.06 Day Low 27.69
Address1 360 North Pastoria Avenue Shares Outstanding 35 M Price Hint 2
Target High Price 32.00 Website https://ceribell.com 52 Week Change 0.1536
Average Volume 309647 Forward Eps -1.10 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 184.00 % Is_sp_500 False
Regular Market Day High 29.06 Profit Margins -60.21 % Debt To Equity 193.57
Fifty Two Week High 29.53 Day High 29.06 Shares Short 229459
Regular Market Open 27.69 Industry Key medical-devices Bid 28.74
Earnings Growth 0.00 % Enterprise To Revenue 19.80 Revenue Growth 48.10 %
Shares Percent Shares Out 0.0092 Operating Cashflow -31743000 Currency USD
Time Zone Full Name America/New_York Market Cap 1 B Is_nasdaq_100 False
Zip 94085 Quote Type EQUITY Industry Medical Devices
Regular Market Day Low 27.69 Held Percent Institutions 0.3839 Current Price 28.84
Enterprise To Ebitda -34.76 Financial Currency USD Current Ratio 2.67
Gross Margins 85.99 % Industry Disp Medical Devices Number Of Analyst Opinions 4
Country United States Float Shares 26 M Two Hundred Day Average 26.75
Enterprise Value 1 B Price To Sales Trailing12 Months 17.21 Forward PE -24.52
Regular Market Volume 73743 Ebitda -34196000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions.

The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting.

It also offers EEG disposable headbands; and pocket-sized battery-operated recorders.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

The company was incorporated in 2014 and is based in Sunnyvale, California.